CAPR logo

Capricor Therapeutics (CAPR)

Profile

Full Name

Capricor Therapeutics, Inc.

Ticker Symbol

CAPR

Exchange

NASDAQ

Country

United States

IPO

February 13, 2007

Indexes

Not included

Employees

160

Key Details

Price

$9.30

Market Cap

$424.79M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$22.27M(-11.55% YoY)

Annual EPS

-$1.15(-38.55% YoY)

PE Ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 HC Wainwright & Co.
Buy
Mar 20, 25 Cantor Fitzgerald
Overweight
Mar 17, 25 HC Wainwright & Co.
Buy
Mar 4, 25 HC Wainwright & Co.
Buy
Jan 2, 25 HC Wainwright & Co.
Buy
Nov 18, 24 Jones Trading
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 14, 24 Cantor Fitzgerald
Overweight
Jul 2, 24 HC Wainwright & Co.
Buy
May 17, 24 Oppenheimer
Outperform

Institutional Ownership

  • What is the ticker symbol for Capricor Therapeutics?
  • Does Capricor Therapeutics pay dividends?
  • What sector is Capricor Therapeutics in?
  • What industry is Capricor Therapeutics in?
  • What country is Capricor Therapeutics based in?
  • When did Capricor Therapeutics go public?
  • Is Capricor Therapeutics in the S&P 500?
  • Is Capricor Therapeutics in the NASDAQ 100?
  • Is Capricor Therapeutics in the Dow Jones?
  • When was Capricor Therapeutics's last earnings report?
  • When does Capricor Therapeutics report earnings?
  • Should I buy Capricor Therapeutics stock now?

What is the ticker symbol for Capricor Therapeutics?

The ticker symbol for Capricor Therapeutics is NASDAQ:CAPR

Does Capricor Therapeutics pay dividends?

No, Capricor Therapeutics does not pay dividends

What sector is Capricor Therapeutics in?

Capricor Therapeutics is in the Healthcare sector

What industry is Capricor Therapeutics in?

Capricor Therapeutics is in the Biotechnology industry

What country is Capricor Therapeutics based in?

Capricor Therapeutics is headquartered in United States

When did Capricor Therapeutics go public?

Capricor Therapeutics's initial public offering (IPO) was on February 13, 2007

Is Capricor Therapeutics in the S&P 500?

No, Capricor Therapeutics is not included in the S&P 500 index

Is Capricor Therapeutics in the NASDAQ 100?

No, Capricor Therapeutics is not included in the NASDAQ 100 index

Is Capricor Therapeutics in the Dow Jones?

No, Capricor Therapeutics is not included in the Dow Jones index

When was Capricor Therapeutics's last earnings report?

Capricor Therapeutics's most recent earnings report was on Mar 19, 2025

When does Capricor Therapeutics report earnings?

The next expected earnings date for Capricor Therapeutics is May 13, 2025

Should I buy Capricor Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page